SusChem founding partner, EuropaBio is inviting biotech start-ups and SMEs from across Europe to apply for the 10th edition of the Most Innovative European Biotech SME Award. This is a unique annual initiative recognising biotech innovation and its contribution to society. SMEs can apply in three categories: healthcare, agricultural or industrial biotechnology. The awards have become one of the highlights of the European biotech calendar, with over 250 SMEs competing since they were started.
The European Commission considers, small and medium-sized enterprises (SMEs) to be the backbone of Europe's economy. They represent 90% of all businesses in the EU. Peter Heinrich, Chair of EuropaBio’s SME Platform highlights: “The majority of the most valuable innovation happens in SMEs, which then go on to form relationships with larger companies, paving the way for improved health, cleaner energy and better environment, for products and processes as well as a sustainable farming for Europe’s societies.”
Biotechnology exemplifies the way in which science and scientific breakthroughs can be applied to respond to some of society’s most difficult challenges. From new therapies that can address unmet medical needs, to industrial processes that use resources more efficiently, to drought-resistant crops that allow farmers to feed a growing population in unpredictable climatic conditions, biotechnology pays economic, societal and environmental dividends.
Tjerk de Ruiter, EuropaBio’s Chair and CEO of Corbion, comments: “The diversity and quality of applications received in previous years demonstrate the entrepreneurial excellence of EU biotech SMEs. They are at the forefront of some critical innovation and are delivering solutions under challenging circumstances. Through these awards we recognise the vital breakthroughs they are making.”
How to enter
Applications for the awards must be submitted online at the dedicated awards website by the end of Sunday 15 September 2019. Two companies will be shortlisted in each of the three categories (healthcare, agricultural or industrial biotechnology) by a Jury of biotech and SME experts, with the winners celebrated during a landmark event to be held in Brussels on 6 November 2019. Each category winner will also receive EUR 10 000 prize money and two years free EuropaBio membership, in addition to European-level exposure and publicity.
The jury experts are all involved in biotech and understand the science, the funding realities and the regulatory and political frameworks in which European biotech SMEs must operate. They appreciate the contribution that innovative SMEs will make to Europe’s future, and together, they will carefully analyse each application to select the final nominees.
To be eligible for an award, participating companies must qualify as an SME under the standard EU SME definition (i.e. primary location of operations within Europe, 250 or less employees, EUR 50 million or less annual turnover).
For more information on the awards including full terms and conditions and success stories from winners of previous awards, please visit the awards website